Living Cell Technologies Ltd. (AU:1AI) has released an update.
Algorae Pharmaceuticals Limited has announced an immediate change in their company secretary, with Ms. Leah Pieris resigning and being replaced by Ms. Maria Clemente. The company expressed gratitude to Ms. Pieris for her service and confirmed that Ms. Clemente would take over the communications with the ASX. Algorae focuses on developing novel treatments for medical conditions using its proprietary AI platform and is publicly traded on the Australian Stock Exchange.
For further insights into AU:1AI stock, check out TipRanks’ Stock Analysis page.